Free Trial

Nature's Sunshine Products (NATR) Competitors

Nature's Sunshine Products logo
$19.79 +0.11 (+0.56%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$19.82 +0.04 (+0.18%)
As of 06/5/2026 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NATR vs. HLF, USNA, NUS, MED, and VERU

Should you buy Nature's Sunshine Products stock or one of its competitors? MarketBeat compares Nature's Sunshine Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nature's Sunshine Products include Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Medifast (MED), and Veru (VERU). These companies are all part of the "personal products" industry.

How does Nature's Sunshine Products compare to Herbalife?

Herbalife (NYSE:HLF) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Herbalife has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

Herbalife has higher revenue and earnings than Nature's Sunshine Products. Herbalife is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Herbalife$5.13B0.23$228.30M$2.285.00
Nature's Sunshine Products$480.14M0.72$19.52M$1.1017.99

In the previous week, Herbalife had 2 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 4 mentions for Herbalife and 2 mentions for Nature's Sunshine Products. Herbalife's average media sentiment score of 1.06 beat Nature's Sunshine Products' score of 0.35 indicating that Herbalife is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Herbalife
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

79.4% of Nature's Sunshine Products shares are owned by institutional investors. 5.1% of Herbalife shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Herbalife has a net margin of 4.67% compared to Nature's Sunshine Products' net margin of 4.06%. Nature's Sunshine Products' return on equity of 14.67% beat Herbalife's return on equity.

Company Net Margins Return on Equity Return on Assets
Herbalife4.67% -41.47% 8.24%
Nature's Sunshine Products 4.06%14.67%9.27%

Herbalife currently has a consensus price target of $17.80, suggesting a potential upside of 56.07%. Nature's Sunshine Products has a consensus price target of $35.00, suggesting a potential upside of 76.86%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, analysts clearly believe Nature's Sunshine Products is more favorable than Herbalife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Herbalife
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Herbalife beats Nature's Sunshine Products on 8 of the 15 factors compared between the two stocks.

How does Nature's Sunshine Products compare to USANA Health Sciences?

Nature's Sunshine Products (NASDAQ:NATR) and USANA Health Sciences (NYSE:USNA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

Nature's Sunshine Products has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

Nature's Sunshine Products has a net margin of 4.06% compared to USANA Health Sciences' net margin of 0.96%. Nature's Sunshine Products' return on equity of 14.67% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Nature's Sunshine Products4.06% 14.67% 9.27%
USANA Health Sciences 0.96%6.21%4.50%

Nature's Sunshine Products has higher earnings, but lower revenue than USANA Health Sciences. Nature's Sunshine Products is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nature's Sunshine Products$480.14M0.72$19.52M$1.1017.99
USANA Health Sciences$925.26M0.36$10.76M$0.4738.34

Nature's Sunshine Products currently has a consensus price target of $35.00, suggesting a potential upside of 76.86%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, research analysts clearly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 3.1% of Nature's Sunshine Products shares are owned by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, USANA Health Sciences had 3 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 5 mentions for USANA Health Sciences and 2 mentions for Nature's Sunshine Products. USANA Health Sciences' average media sentiment score of 0.60 beat Nature's Sunshine Products' score of 0.35 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
USANA Health Sciences
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Nature's Sunshine Products beats USANA Health Sciences on 12 of the 16 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

In the previous week, Nature's Sunshine Products had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for Nature's Sunshine Products and 0 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 1.00 beat Nature's Sunshine Products' score of 0.35 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company Overall Sentiment
Nu Skin Enterprises Positive
Nature's Sunshine Products Neutral

Nu Skin Enterprises has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.44B0.18$160.20M$1.104.90
Nature's Sunshine Products$480.14M0.72$19.52M$1.1017.99

82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Nature's Sunshine Products has a consensus target price of $35.00, indicating a potential upside of 76.86%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts clearly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises3.78% 7.47% 4.21%
Nature's Sunshine Products 4.06%14.67%9.27%

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 10 of the 15 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Medifast?

Nature's Sunshine Products (NASDAQ:NATR) and Medifast (NYSE:MED) are both small-cap personal products companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Nature's Sunshine Products has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nature's Sunshine Products$480.14M0.72$19.52M$1.1017.99
Medifast$346.10M0.39-$18.67M-$1.83N/A

Nature's Sunshine Products has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, Medifast has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

Nature's Sunshine Products currently has a consensus target price of $35.00, suggesting a potential upside of 76.86%. Medifast has a consensus target price of $12.00, suggesting a potential downside of 0.62%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, equities analysts clearly believe Nature's Sunshine Products is more favorable than Medifast.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Medifast
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Nature's Sunshine Products has a net margin of 4.06% compared to Medifast's net margin of -5.78%. Nature's Sunshine Products' return on equity of 14.67% beat Medifast's return on equity.

Company Net Margins Return on Equity Return on Assets
Nature's Sunshine Products4.06% 14.67% 9.27%
Medifast -5.78%-4.80%-3.83%

In the previous week, Nature's Sunshine Products and Nature's Sunshine Products both had 2 articles in the media. Nature's Sunshine Products' average media sentiment score of 0.35 beat Medifast's score of 0.12 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Medifast
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 95.5% of Medifast shares are owned by institutional investors. 3.1% of Nature's Sunshine Products shares are owned by insiders. Comparatively, 3.7% of Medifast shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Nature's Sunshine Products beats Medifast on 13 of the 15 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Veru?

Nature's Sunshine Products (NASDAQ:NATR) and Veru (NASDAQ:VERU) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Nature's Sunshine Products has a net margin of 4.06% compared to Veru's net margin of 0.00%. Nature's Sunshine Products' return on equity of 14.67% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Nature's Sunshine Products4.06% 14.67% 9.27%
Veru N/A -54.72%-39.09%

Nature's Sunshine Products has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Veru has a beta of -1.14, meaning that its share price is 214% less volatile than the broader market.

In the previous week, Veru had 5 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 7 mentions for Veru and 2 mentions for Nature's Sunshine Products. Veru's average media sentiment score of 0.57 beat Nature's Sunshine Products' score of 0.35 indicating that Veru is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Veru
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 3.1% of Nature's Sunshine Products shares are owned by company insiders. Comparatively, 14.2% of Veru shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Nature's Sunshine Products presently has a consensus price target of $35.00, suggesting a potential upside of 76.86%. Veru has a consensus price target of $23.00, suggesting a potential upside of 576.47%. Given Veru's higher probable upside, analysts clearly believe Veru is more favorable than Nature's Sunshine Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nature's Sunshine Products$480.14M0.72$19.52M$1.1017.99
Veru$16.89M3.23-$22.73M-$0.89N/A

Summary

Nature's Sunshine Products beats Veru on 10 of the 15 factors compared between the two stocks.

Get Nature's Sunshine Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NATR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NATR vs. The Competition

MetricNature's Sunshine ProductsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$346.07M$2.98B$6.47B$12.42B
Dividend YieldN/A1.70%2.68%5.33%
P/E Ratio17.9917.8623.7923.63
Price / Sales0.72434.60543.19124.83
Price / Cash9.0556.2142.3557.17
Price / Book2.143.839.736.35
Net Income$19.52M$75.85M$3.57B$337.59M
7 Day Performance-7.00%-1.85%-1.24%-2.51%
1 Month Performance-24.58%-7.67%0.83%-0.68%
1 Year Performance36.39%14.97%24.11%25.37%

Nature's Sunshine Products Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NATR
Nature's Sunshine Products
3.815 of 5 stars
$19.79
+0.6%
$35.00
+76.9%
+35.9%$346.07M$480.14M17.99850
HLF
Herbalife
4.8741 of 5 stars
$12.00
+0.8%
$17.80
+48.3%
+52.8%$1.23B$5.04B5.268,500
USNA
USANA Health Sciences
2.795 of 5 stars
$18.09
-1.3%
N/A-37.9%$338.43M$925.26M38.491,570
NUS
Nu Skin Enterprises
3.4181 of 5 stars
$5.62
-0.3%
N/A-30.7%$273.34M$1.49B5.102,800
MED
Medifast
1.369 of 5 stars
$12.38
-2.5%
$12.00
-3.1%
-3.3%$141.21M$385.79MN/A870

Related Companies and Tools


This page (NASDAQ:NATR) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners